This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, Y. Q.
Right arrow Articles by North, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, Y. Q.
Right arrow Articles by North, T. W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Sep 1996, 1983-1987, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy- 2',3'-didehydrothymidine

YQ Zhu, KM Remington and TW North
Division of Biological Sciences, University of Montana, Missoula 59812, USA.

We selected mutants of feline immunodeficiency virus (FIV) that are resistant to 2',3'-dideoxy-2',3'-didehydrothymidine (d4T). Two mutants were selected in cultured cells with a stepwise increase in d4T concentration, resulting in mutants able to replicate in 100 microM d4T. These mutants were three- to sixfold more resistant to d4T than wild-type FIV. They were also cross-resistant to 3'-azido-3'- deoxythymidine (AZT), 3'-fluoro-2',3'-dideoxythymidine, 2',3'- dideoxycytidine, 2',3'-dideoxyinosine, and 9-(2- phosphonylmethoxyethyl)adenine, and they were highly resistant to phosphonoformic acid (PFA). Plaque-purified mutants were isolated from each of the mutant populations. The mutant phenotype was stable, because both of the plaque-purified mutants remained d4T resistant even after three passages in the absence of d4T. One of the plaque-purified mutants, designated D4R-3c, was further characterized. Compared with wild-type reverse transcriptase (RT), RT purified from D4R-3c was 3- fold resistant to inhibition by the 5'-triphosphate of d4T, 10-fold resistant to inhibition by the 5'-triphosphate of AZT, and 6-fold resistant to PFA. D4R-3c had a single point mutation in the RT-encoding region of the pol gene at position 2474, resulting in a Val to Ile mutation at codon 47 of the FIV RT. The role of this mutation in d4T resistance was confirmed by site-directed mutagenesis.


This article has been cited by other articles:

  • Martins, A. N., Medeiros, S. O., Simonetti, J. P., Schatzmayr, H. G., Tanuri, A., Brindeiro, R. M. (2008). Phylogenetic and Genetic Analysis of Feline Immunodeficiency Virus gag, pol, and env Genes from Domestic Cats Undergoing Nucleoside Reverse Transcriptase Inhibitor Treatment or Treatment-Naive Cats in Rio de Janeiro, Brazil. J. Virol. 82: 7863-7874 [Abstract] [Full Text]  
  • Smith, R. A., Remington, K. M., Preston, B. D., Schinazi, R. F., North, T. W. (1998). A Novel Point Mutation at Position 156 of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to the Combination of (-)-beta -2',3'-Dideoxy-3'-Thiacytidine and 3'-Azido-3'-Deoxythymidine. J. Virol. 72: 2335-2340 [Abstract] [Full Text]